| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/02/2000 | US6057427 Antibody or fragment which binds to specific amino acid sequence; for peptide/protein purification |
| 05/02/2000 | US6057423 Screening a recombinantly-produced or chemically-synthesized molecular library to identify compounds which suppress binding between human mucosal lymphocyte-1 antigen comprising an integrin alpha e chain and an epithelial cell in vitro |
| 05/02/2000 | US6057142 Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
| 05/02/2000 | US6057122 Antiangiogenic peptides polynucleotides encoding same and methods for inhibiting angiogenesis |
| 05/02/2000 | US6057115 Process for producing GM2 specific antibodies |
| 05/02/2000 | US6057096 Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| 05/02/2000 | US6056964 Delaying or preventing the growth or spread of a malignant neoplasm by administering killed cells of mycobacterium vaccae |
| 05/02/2000 | US6056963 Immunogenic compositions comprising glycosylated and deglycosylated monomeric and dimeric forms of HIV-2 enveloped glycoproteins |
| 05/02/2000 | US6056960 Pertussis toxin and its analogs exhibiting adp-ribosyltransferase activity; tumor-related antigen comprising tumor cells, irradiated tumor cells, or tumor-associated antigens |
| 05/02/2000 | US6056959 CD40 antigen antibody complex |
| 05/02/2000 | US6056952 Selective elimination of T cells that recognize specific preselected targets |
| 05/02/2000 | CA2109233C Process for producing vaccine for bacterial toxin belonging to rtx toxin family |
| 05/02/2000 | CA2105057C Dna sequences which code for virulence characteristics of streptococcus suis and part thereof polypeptides and antibodies derived therefrom and the use thereof for the diagnosis of and protection against infection by s. suis in mammals, including man |
| 05/02/2000 | CA2104014C Structural gene of pneumococcal protein |
| 05/02/2000 | CA2060198C Method of preparing vaccines against rna viruses |
| 05/02/2000 | CA2011878C Immunogenic regions on the e7 protein of human papillomavirus type 16 |
| 05/02/2000 | CA1340982C Protamine-reactive igm antibodies |
| 04/27/2000 | WO2000023955A1 Virus-like particles for the induction of autoantibodies |
| 04/27/2000 | WO2000023595A1 Omp85 proteins of neisseria gonorrhoeae and neisseria meningitidis, compositions containing same and methods of use thereof |
| 04/27/2000 | WO2000023592A2 Minimal promoters and uses thereof |
| 04/27/2000 | WO2000023584A1 Camel, an alternative translation product of the tumour antigen lage-1 |
| 04/27/2000 | WO2000023575A1 Ups (ugc) |
| 04/27/2000 | WO2000023574A2 Hepatitis a vaccines |
| 04/27/2000 | WO2000023462A1 Method for the production of purified invasin protein and use thereof |
| 04/27/2000 | WO2000023115A1 TREATMENT OF TRAUMA (I.E. GRAFT REJECTION) WITH LIPOSOMES CONTAINING DNA ENCODING FOR CTLA4Ig OR FOR ANTI-CD40L |
| 04/27/2000 | WO2000023114A2 Polymer conjugates of interferon beta- 1a and their uses |
| 04/27/2000 | WO2000023111A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 04/27/2000 | WO2000023108A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 04/27/2000 | WO2000023107A1 Vaccine preparations containing attenuated toxin |
| 04/27/2000 | WO2000023106A1 Bacterial extract as oral adjuvant |
| 04/27/2000 | WO2000023105A2 Adjuvant systems and vaccines |
| 04/27/2000 | WO2000023104A1 Freeze-dried hepatitis a attenuated live vaccine and its stabilizer |
| 04/27/2000 | WO2000023103A1 Viral mastitis |
| 04/27/2000 | WO2000023088A2 Methods of administering adenoviral vectors |
| 04/27/2000 | WO2000023087A1 Polyspecific binding molecules and uses thereof |
| 04/27/2000 | WO2000023082A1 Treatment of systemic lupus erythematosus by down-regulating the autoimmune response to autoantigens |
| 04/27/2000 | WO2000023053A2 Artificial antigen-specific cells and related methods |
| 04/27/2000 | WO2000006742A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 04/27/2000 | WO2000005265A3 Anti-crr2 antibodies and methods of use therefor |
| 04/27/2000 | WO2000004920A3 Method of vaccination of newly hatched poultry |
| 04/27/2000 | WO2000004919A3 Live attenuated salmonella vaccines to control avian pathogens |
| 04/27/2000 | WO2000003744A3 Adjuvant and vaccine compositions containing monophosphoryl lipid a |
| 04/27/2000 | WO1999064586A3 Phagocytic assay method |
| 04/27/2000 | WO1999061596A3 Novel post-transcriptional regulatory elements and uses thereof |
| 04/27/2000 | WO1999061085A9 Method and compositions for treatment of cancers |
| 04/27/2000 | WO1999057271A9 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides |
| 04/27/2000 | WO1999006544A8 Membrane-bound cytokine compositions and methods of modulating an immune response using same |
| 04/27/2000 | DE19849044A1 New polycythemia rubra vera-related polypeptide useful for diagnosis and for developing therapeutic antibodies |
| 04/27/2000 | DE19847142A1 Diagnosing borelliosis by detecting specific antibodies, using new Borellia antigens expressed preferentially during infection and also useful as immunogens in vaccines |
| 04/27/2000 | DE19842863A1 Regulatorisches Protein aus humanen Keratinozyten Regulatory protein from human keratinocytes |
| 04/27/2000 | CA2773698A1 Adjuvant systems comprising an immunostimulant adsorbed to a metallic salt particle and vaccines thereof |
| 04/27/2000 | CA2354862A1 Treatment of systemic lupus erythematosus by down-regulating the autoimmune response to autoantigens |
| 04/27/2000 | CA2347937A1 Method for the production of purified invasin protein and use thereof |
| 04/27/2000 | CA2347849A1 Omp85 proteins of neisseria gonorrhoeae and neisseria meningitidis, compositions containing same and methods of use thereof |
| 04/27/2000 | CA2347369A1 Minimal promoters and uses thereof |
| 04/27/2000 | CA2347099A1 Adjuvant systems comprising an immunostimulant adsorbed to a metallic salt particle and vaccines thereof |
| 04/27/2000 | CA2347085A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 04/27/2000 | CA2347083A1 Methods of administering adenoviral vectors |
| 04/27/2000 | CA2347081A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 04/27/2000 | CA2346942A1 Camel, an alternative translation product of the tumour antigen lage-1 |
| 04/26/2000 | EP0995799A2 Coccidiosis vaccines |
| 04/26/2000 | EP0995798A1 Transcription factor of MHC class II genes, substances capable of inhibiting this new transcription factor and medical uses of these substances |
| 04/26/2000 | EP0994959A1 Polymer-modified viruses |
| 04/26/2000 | EP0994949A1 Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences |
| 04/26/2000 | EP0994948A1 TGF$g(b) RII RECEPTOR NUCLEIC SEQUENCE, CODED PEPTIDE, AND USES |
| 04/26/2000 | EP0994946A1 Coding sequence haplotypes of the human brca2 gene |
| 04/26/2000 | EP0994944A1 Method of attenuating pathogenic mycobacteria and strains of mycobacteria so attenuated |
| 04/26/2000 | EP0994904A2 AMINO ACID SEQUENCES FOR THERAPEUTICAL AND PROPHYLACTIC APPLICATIONS TO DISEASES DUE TO $i(CLOSTRIDIUM DIFFICILE) TOXINS |
| 04/26/2000 | EP0994903A1 Methods and compositions for galactosylated glycoproteins |
| 04/26/2000 | EP0994887A2 Modified glycosides, compositions comprised thereof and methods of use thereof |
| 04/26/2000 | EP0994724A1 Methods and compositions for impairing multiplication of hiv-1 |
| 04/26/2000 | EP0994723A1 Methods of immunizing adults using anti-meningococcal vaccine compositions |
| 04/26/2000 | EP0994722A1 Method of removing endotoxin from vaccines |
| 04/26/2000 | EP0994721A1 Nerve growth factor as a vaccine adjuvant |
| 04/26/2000 | EP0994720A1 Use of bromelain in the manufacture of a medicament for enhancement of intestinal permeability |
| 04/26/2000 | EP0994717A1 Treatment of autoimmune disease using tolerization in combination with methotrexate |
| 04/26/2000 | EP0925305B1 Cyclitol containing carbohydrates from human tissue which regulate lipogenic activity |
| 04/26/2000 | EP0925304B1 Cyclitol containing carbohydrates from human tissue which regulate glycogen metabolism |
| 04/26/2000 | EP0832127B1 Synthetic peptides and pharmaceutical compositions comprising them |
| 04/26/2000 | EP0789716B1 Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for the determination thereof |
| 04/26/2000 | EP0656945B1 Stress protein epitopes |
| 04/26/2000 | EP0656013B1 Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus |
| 04/26/2000 | EP0633930B1 In vitro generation of human dendritic cells |
| 04/26/2000 | CN1251611A USPA1 and USPA2 antigens of moraxelia catarrhalis |
| 04/25/2000 | US6054573 Highly infectious rubella virus clones and methods of production |
| 04/25/2000 | US6054572 Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion |
| 04/25/2000 | US6054567 Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
| 04/25/2000 | US6054565 Nucleic Acids of HIV-2, Diagnostic Test Kit and Method using Nucleic Acid Probes of HIV-2 |
| 04/25/2000 | US6054560 Mitogen activated protein kinase, FRK |
| 04/25/2000 | US6054308 Arginase II |
| 04/25/2000 | US6054303 Cyclosporins conjugated at an alanine nitrogen atom to an immunogenic carrier, a ligand, a small organic compound or a label through a linker of alkylene oxide chain or carbonyloxybenzyl group including 1-3 carboxamide groups |
| 04/25/2000 | US6054296 66 kDa antigen from Borrelia |
| 04/25/2000 | US6054284 Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type I (HIV-1) GP120 and methods of use |
| 04/25/2000 | US6054273 Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents |
| 04/25/2000 | US6054265 Screening assays for compounds that inhibit membrane fusion-associated events |
| 04/25/2000 | US6054264 Methods of typing hepatitis C virus and reagents for use therein |
| 04/25/2000 | US6054135 Compounds and methods for the detection and prevention of T. cruzi infection |
| 04/25/2000 | US6054134 An immunogen which binds specifically to phosphatidylethanolamine, gangliotriaosylceramide and gangliotetraosylceramide; protecting susceptible mammals from diseases caused by bacterial influenzae pathogens |
| 04/25/2000 | US6054132 A purified toxin in diagnostic testing for detecting peptic ulceration and gastric malignancy, and as a vaccine for providing immunologic protection against bacterial infection |
| 04/25/2000 | US6054131 Vaccine composition for herpes simplex virus and method of using |